| Quarter | Score |
|---|---|
| 2022-Q3 | 66.6 |
| 2022-Q4 | 49.7 |
| 2023-Q1 | 49.4 |
| 2023-Q2 | 36.3 |
| 2023-Q3 | 48.8 |
| 2023-Q4 | 36.0 |
| 2024-Q1 | 49.9 |
| 2024-Q2 | 74.1 |
| 2024-Q3 | 75.2 |
| 2024-Q4 | 77.3 |
| 2025-Q1 | 74.9 |
| 2025-Q2 | 82.2 |
| 2025-Q3 | 75.8 |
| 2025-Q4 | 76.1 |
| 2026-Q1 | 78.0 |
| 2026-Q2 | 79.5 |
Strong consensus, but price is extended — wait for pullback to funds' basis
Trading +68.0% above funds' purchase price — elevated pullback risk
3 of 18 tracked funds hold ASML. Avg conviction: 0.9%. Net adding. First tracked at $1041.52 (current +68.0% vs tracked).
Appaloosa Management has 1.3% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Appaloosa Management | 1.3% | Add |
| Third Point | 1.3% | Add |
| Citadel Advisors | 0.0% | Reduce |